Source: European Medicines Agency (EU) Revision Year: 2021 Publisher: Novartis Europharm Limited, Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland
AZOPT 10 mg/ml eye drops, suspension.
| Pharmaceutical Form |
|---|
|
Eye drops, suspension. White to off-white suspension. |
Each ml of suspension contains 10 mg brinzolamide.
Excipient with known effect: Each ml of suspension contains 0.1 mg benzalkonium chloride.
For a full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Brinzolamide is an inhibitor of carbonic anhydrase II (CA-II). Carbonic anhydrase (CA) is an enzyme found in many tissues of the body, including the eye. Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humour secretion resulting in a reduction in intraocular pressure (IOP) which is a major risk factor in the pathogenesis of optic nerve damage and glaucomatous visual field loss. |
| List of Excipients |
|---|
|
Benzalkonium chloride |
5 and 10 ml opaque low density polyethylene bottles with polypropylene screw caps (droptainer).
The following pack sizes are available: outer cartons containing 1 × 5 ml, 3 × 5 ml and 1 × 10 ml bottles. Not all pack sizes may be marketed.
Novartis Europharm Limited, Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland
EU/1/00/129/001-3
Date of first authorisation: 9 March 2000
Date of latest renewal: 29 January 2010
| Drug | Countries | |
|---|---|---|
| AZOPT | Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.